KeyCorp director granted 1,558 deferred shares
Rankin Devina A reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Rankin Devina A reported acquisition or exercise transactions in this Form 4 filing.
KeyCorp director Devina A. Rankin received 1,558 deferred shares as a grant of director fees under the company’s Deferred Share Plan. These deferred shares are economically equivalent to common shares but will not be paid out until the earlier of January 1, 2029, or her death.
Following this award, she holds 81,765 deferred shares and 13,430 common shares directly. The filing also notes that this deferred position includes approximately 861 dividend-equivalent deferred shares accrued in March 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Shares | 1,558 | $20.05 | $31K |
| holding | Common Shares | -- | -- | -- |
Footnotes (3)
- F1. Directors may elect to defer the payment of directors' fees into the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan (the "Deferred Share Plan"). The deferred fees are converted into deferred shares, which are the economic equivalent of common shares.
- F2. Under the terms of the Deferred Share Plan, payment of the deferred shares has been deferred until the earlier of January 1, 2029, or the death of the participant.
- F3. Includes approximately 861 dividend-equivalent deferred shares accrued under the Deferred Share Plan in March 2026.
Key Figures
Key Terms
Equity Compensation Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did KeyCorp (KEY) director Devina A. Rankin report on this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.